Growing Innovation In Australian Life Science

EMBL Australia will avail itself of a highly successful model for commercial outreach, driven by the EMBL Enterprise Management Technology Transfer GmbH (EMBLEM), an affiliate and the commercial arm of the European Molecular Biology Laboratory (EMBL). EMBLEM, established in 1999 identifies, protects and commercialises the intellectual property developed in the EMBL-world, from EMBL-alumni and from third parties. EMBLEM facilitates and accelerates the transfer of innovative technology from basic research to industry by working closely with industrial partners spanning the biotech, ITC and mechanical/electrical engineering markets to develop new diagnostics, drugs, therapies and machines and devices. EMBLEM currently manages a portfolio of more than 170 patent families/copyrights and over 200 license contracts. Their technology portfolio spans the Life Sciences in the broadest sense involving identification and commercial development of life science technologies and includes enabling technologies, molecular tools and techniques, instruments, as well as software programs and databases. EMBLEM also assists in marketing and contracting of scientific consultancy services; advising and structuring EMBL spin-off companies; and is active in training and education. EMBLEM has already liaised with EMBL Australia participating institutions, to consult and offer assistance in capturing EMBL Australia’s potential for innovation and commercial opportunities.